Therapeutic Strategy for Differentiated Thyroid Carcinoma in Japan Based on a Newly Established Guideline Managed by Japanese Society of Thyroid Surgeons and Japanese Association of Endocrine Surgeons

摘要

Background Therapeutic strategy for patients with differentiated thyroid carcinoma (DTC) in Japan has differed from that in Western countries. Total thyroidectomy followed by radioactive iodine (RAI) ablation has been a standard therapy in Western countries, while limited thyroidectomy has been widely accepted in Japan. We newly established guidelines for clinical practice in treating thyroid tumors based on evidence from previous publications and the accumulation of data from patients in Japan. We present our therapeutic recommendations for DTC patients based on these guidelines.